Teleflex Inc at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) Transcript

Mar 21, 2023 / 04:00PM GMT
Matthew Ian Mishan - KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research Analyst

Good afternoon. I'd like to welcome everyone to the KeyBanc Life Sciences & MedTech Investor Forum. My name is Matt Mishan. I'm our senior med tech analyst and I'm pleased to be joined by Teleflex, who is represented today by Tom Powell, Executive Vice President and CFO; as well as Larry Keusch, VP of IR and Strategy Development. For the audience, I'm going to start this off, but questions can be submitted directly to me by typing in the box below on the video screen and I can relay. Tom, Larry, thank you very much for joining us.

Questions and Answers:

Matthew Ian Mishan - KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research Analyst

I think my opening question is pretty straightforward. Just how would you compare the current environment and your level of visibility at the start of 2023 to what you saw over the last couple of years?

Thomas E. Powell - Teleflex Incorporated - Executive
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot